These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29688833)

  • 1. Diabetes After Hormone Therapy in Breast Cancer Survivors: A Case-Cohort Study.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    J Clin Oncol; 2018 Jul; 36(20):2061-2069. PubMed ID: 29688833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    Osteoporos Int; 2019 Jan; 30(1):187-200. PubMed ID: 30413856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.
    Chlebowski RT; Schottinger JE; Shi J; Chung J; Haque R
    Cancer; 2015 Jul; 121(13):2147-55. PubMed ID: 25757699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
    Rillamas-Sun E; Kwan ML; Iribarren C; Cheng R; Neugebauer R; Rana JS; Nguyen-Huynh M; Shi Z; Laurent CA; Lee VS; Roh JM; Huang Y; Shen H; Hershman DL; Kushi LH; Greenlee H
    Breast Cancer Res Treat; 2023 Aug; 201(1):117-126. PubMed ID: 37326764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer.
    Sun LM; Chen HJ; Liang JA; Li TC; Kao CH
    Br J Cancer; 2014 Oct; 111(9):1836-42. PubMed ID: 25225901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.
    Wu CT; Lai JN; Tsai YT
    PLoS One; 2014; 9(12):e113887. PubMed ID: 25485843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.
    Santorelli ML; Hirshfield KM; Steinberg MB; Rhoads GG; Lin Y; Demissie K
    Ann Epidemiol; 2016 Jun; 26(6):436-40. PubMed ID: 27157863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.
    Xu X; Chlebowski RT; Shi J; Barac A; Haque R
    Breast Cancer Res Treat; 2019 Apr; 174(3):785-794. PubMed ID: 30659431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.
    Wadström H; Pettersson A; Smedby KE; Askling J
    Ann Rheum Dis; 2020 May; 79(5):581-586. PubMed ID: 32161056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
    He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K
    J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
    Fisher B; Dignam J; Bryant J; DeCillis A; Wickerham DL; Wolmark N; Costantino J; Redmond C; Fisher ER; Bowman DM; Deschênes L; Dimitrov NV; Margolese RG; Robidoux A; Shibata H; Terz J; Paterson AH; Feldman MI; Farrar W; Evans J; Lickley HL
    J Natl Cancer Inst; 1996 Nov; 88(21):1529-42. PubMed ID: 8901851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
    Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
    J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
    Baum M; Buzdar A; Cuzick J; Forbes J; Houghton J; Howell A; Sahmoud T;
    Cancer; 2003 Nov; 98(9):1802-10. PubMed ID: 14584060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up.
    Rosell J; Nordenskjöld B; Bengtsson NO; Fornander T; Hatschek T; Lindman H; Malmström PO; Wallgren A; Stål O; Carstensen J
    Breast Cancer Res Treat; 2013 Apr; 138(2):467-73. PubMed ID: 23456195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between tamoxifen treatment and diabetes: a population-based study.
    Lipscombe LL; Fischer HD; Yun L; Gruneir A; Austin P; Paszat L; Anderson GM; Rochon PA
    Cancer; 2012 May; 118(10):2615-22. PubMed ID: 21935915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
    Keating NL; O'Malley AJ; Smith MR
    J Clin Oncol; 2006 Sep; 24(27):4448-56. PubMed ID: 16983113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.